4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-22-060387
Chief Executive Officer acquired 58,233 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…